Opinion on Therapy Area in Europe

Published within

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

Type Product title / description Pub Price
CommentWire
CommentWire

Myriad Genetics: an unusually successful collaborator

Published By Datamonitor
23 Oct 2000
CommentWire
CommentWire

Antisoma: changing product range, but not direction

Published By Datamonitor
30 Oct 2000
CommentWire
CommentWire

Glaxo Wellcome: taking some of the tension out of anti-hypertension

Published By Datamonitor
01 Nov 2000
CommentWire
CommentWire

ADHD: NICE ruling for Ritalin, but will it boost sales?

Published By Datamonitor
02 Nov 2000
CommentWire
CommentWire

KS BioMedix: an alternative route to the marketplace

Published By Datamonitor
06 Nov 2000
CommentWire
CommentWire

Raisio: Benecol isn't beneficial to the bottom line

Published By Datamonitor
09 Nov 2000
CommentWire
CommentWire

Multiple sclerosis: NICE to reconsider decision

Published By Datamonitor
09 Nov 2000
Expert View
Expert View

Opening the door to Japanese markets

Published By Datamonitor
08 Dec 2000
CommentWire
CommentWire

Shire Pharmaceuticals: transatlantic growth spurt

Published By Datamonitor
11 Dec 2000
CommentWire
CommentWire

Vernalis: benefiting from SB's regulatory headaches

Published By Datamonitor
14 Dec 2000

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

No help is available.